Apparent argatroban resistance in a patient with elevated factor VIII levels.
about
Limitation of the activated partial thromboplastin time as a monitoring method of the direct thrombin inhibitor argatroban.Direct Thrombin Inhibitor Resistance and Possible Mechanisms.Simultaneous Left Ventricular and Deep Vein Thrombi Caused by Protein C Deficiency.Elevated Factor VIII Levels Associated with Acute Graft Occlusion and Arterial and Venous Thrombosis After Off Pump CABG.Monitoring of argatroban and lepirudin anticoagulation in critically ill patients by conventional laboratory parameters and rotational thromboelastometry - a prospectively controlled randomized double-blind clinical trial.Argatroban monitoring: aPTT versus chromogenic assay.
P2860
Apparent argatroban resistance in a patient with elevated factor VIII levels.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Apparent argatroban resistance in a patient with elevated factor VIII levels.
@ast
Apparent argatroban resistance in a patient with elevated factor VIII levels.
@en
type
label
Apparent argatroban resistance in a patient with elevated factor VIII levels.
@ast
Apparent argatroban resistance in a patient with elevated factor VIII levels.
@en
prefLabel
Apparent argatroban resistance in a patient with elevated factor VIII levels.
@ast
Apparent argatroban resistance in a patient with elevated factor VIII levels.
@en
P2860
P356
P1476
Apparent argatroban resistance in a patient with elevated factor VIII levels.
@en
P2093
Cesar Alaniz
Dina M Kennedy
P2860
P356
10.1345/APH.1R745
P407
P577
2013-06-04T00:00:00Z